a GenomeWeb staff reporter

This story has been updated to include comments from Nanion Technologies.

NEW YORK (GenomeWeb News) — The European Patent Office has upheld Molecular Devices' foundation planar patch-clamp patent, but with amendments, ending a dispute filed against the patent by Nanion Technologies.

The ruling is final and cannot be appealed. The EPO will issue a written decision in the near future, Molecular Devices said in a statement issued on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.